EcoDrugPlus

Carbonic Anhydrase 2

Ensembl ID : ENSPEMG00000011693
Gene Symbol: CA2
3 Cross references
282 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSPEMG00000007557
Gene Symbol: CA3
3 Cross references
307 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSPEMG00000010937
Gene Symbol: CA4
3 Cross references
267 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSPEMG00000014305
Gene Symbol: CA5B
3 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 5a, Mitochondrial

Ensembl ID : ENSPEMG00000023182
Gene Symbol: CAR5A
1 Cross references
167 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSPEMG00000009187
Gene Symbol: CA7
3 Cross references
220 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSPEMG00000016572
Gene Symbol: CA9
3 Cross references
280 Possible Orthologues:

Casein Kinase I Isoform Epsilon

Ensembl ID : ENSPEMG00000020952
Gene Symbol: LOC102921851
3 Cross references
268 Possible Orthologues:

Caspase 8

Ensembl ID : ENSPEMG00000021544
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSPEMG00000022246
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSPEMG00000023091
Gene Symbol: CTSC
3 Cross references
233 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSPEMG00000001057
Gene Symbol: CTSK
3 Cross references
240 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).